SCHEMBL7708174

SCHEMBL7708174

CCC(c1ccc2c(c1)NC(N)=C(C)O2)N(Cc1cccs1)C(=O)OC(C)(C)C

nearest known ligand 0.37

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
GAA P10253 2/20 0.37
HTT P42858 2/20 0.37
NPSR1 Q6W5P4 1/20 0.37
POLB P06746 1/20 0.36
TRPM8 Q7Z2W7 11/20 0.35
RIPK1 Q13546 1/20 0.33
ALDH1A1 P00352 4/20 0.33
LMNA P02545 2/20 0.33
RAB9A P51151 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.33
TP53 P04637 1/20 0.32
MAPT P10636 1/20 0.32
SMN1; SMN2 Q16637 1/20 0.32
CYP3A4 P08684 1/20 0.32
CYP2C9 P11712 1/20 0.32
CYP2C19 P33261 1/20 0.32
CHRM2 P08172 1/20 0.31
CHRM1 P11229 1/20 0.31
CHRM3 P20309 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7710216 0.88 HSD17B10 (0.35) POLBTRPM8ALDH1A1LMNAL3MBTL1
SCHEMBL7711223 0.82 PARP1 (0.38) GAAHTTNPSR1POLBTRPM8
SCHEMBL7089254 0.82 HTT (0.35) GAAHTTNPSR1POLBTRPM8
SCHEMBL7708337 0.78 ALDH1A1 (0.30) ALDH1A1
SCHEMBL7708180 0.77 HTT (0.34) GAAHTTNPSR1POLBTRPM8
SCHEMBL7710851 0.73 AAK1 (0.31)
SCHEMBL6995053 0.72 POLB (0.34) POLBTRPM8ALDH1A1LMNAL3MBTL1
SCHEMBL7704910 0.72 HDAC1 (0.45) NPSR1ALDH1A1SMN1; SMN2
SCHEMBL7704892 0.72
SCHEMBL7711553 0.71 CYP2C19 (0.32) CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6365736-B1 TREATMENT OF NERVOUS SYSTEM DISORDERS, CARDIOVASCULAR DISORDERS AND FOR ACTIVITY AS NO-SYNTHASES (NOS) INHIBITORS. SCHERING AKTIENGESELLSCHAFT (DE) 2002-04-02 US disclosed